[1] Dose-escalation studies, such as a 12-week trial on gradual titration, revealed that beginning at lower doses (e.g., 4 mg) and slowly increasing to therapeutic levels significantly reduced the incidence of nausea, vomiting, and diarrhoea
The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury
People with severe pre-existing motility disorders may experience worsening of the symptoms such as nausea, vomiting, or bloating
He explains that the studys primary end point a composite of cardiovascular death, MI or stroke was chosen because it was the end point of the REWIND trial that supported dulaglutides regulatory approval for reduction of major adverse cardiovascular events
Learn More from the Blog How to Transition Your Dog to a New Food Switching your dogs food can seem overwhelming, but with a structured plan, you can make the transition smooth and stress-free for you and your furry friend